Form 4: 23andMe CFO Sells Shares to Cover Tax Obligations

23andMe's Chief Financial Officer, Joseph Selsavage, disposed of 5,279 shares of Class A Common Stock to cover tax obligations.

Summary

• Joseph Selsavage, the Chief Financial Officer of 23andMe Holding Co., sold 5,279 shares of Class A Common Stock on November 20, 2024.
• The sale was executed at a price of $3.15 per share.
• This transaction was to cover tax obligations related to the vesting of shares.
• Following the transaction, Mr. Selsavage beneficially owns 102,122 shares of 23andMe stock.
• The share amounts have been adjusted to reflect a 1-for-20 reverse stock split that occurred on October 16, 2024.

Sentiment

Score: 5

Explanation: The document reflects a routine insider transaction for tax purposes, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider sales for tax purposes.
• Other companies in the biotechnology and personal genomics space also have similar filings when executives sell shares.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors as it is a routine insider sale.

Key Dates

Keywords

23andMe, insider trading, SEC Form 4, stock sale, Joseph Selsavage, CFO, tax obligations, reverse stock split